By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
No recent information was found.
Currency | Euro |
Share Price | 84.95 |
Change Today | 1.41 |
% Change | 1.69 % |
52 Week High | 109.62 |
52 Week Low | 78.84 |
Volume | 1,594,147 |
Shares Issued | 1,256.00m |
Market Cap | 106,697m |
Beta | 0.74 |
Strong Buy | 13 |
Buy | 7 |
Neutral | 7 |
Sell | 0 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
17:37 | 588 @ 84.95 |
17:37 | 1,171 @ 84.95 |
17:37 | 851 @ 84.95 |
17:37 | 1,868 @ 84.95 |
17:37 | 344 @ 84.95 |
You are here: research